LURASIDONE HYDROCHLORIDE is indicated for the treatment of patients with schizophrenia.
LATUDA is branded formulation of LURASIDONE HYDROCHLORIDE. LATUDA launched by SUNOVION PHARMS INC on October 28, 2010. LATUDA is available in Tablet dosage form and in multiple strength (20MG, 40MG, 60MG, 80MG, 120MG).
EMCURE PHARMS LTD, LUPIN LTD, MSN LABORATORIES, SUN PHARMA GLOBAL have already got tentative approval for LURASIDONE HYDROCHLORIDE in USA.
Follow the below link for formulation literature of Lurasidone:
No comments:
Post a Comment